...
首页> 外文期刊>The Journal of Steroid Biochemistry and Molecular Biology >Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-hydroxyphenyl ketones as potent and specific inhibitors of the type 3 of 17beta-hydroxysteroid dehydrogenase (17beta-HSD3).
【24h】

Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-hydroxyphenyl ketones as potent and specific inhibitors of the type 3 of 17beta-hydroxysteroid dehydrogenase (17beta-HSD3).

机译:合成,生化评估和合理化一系列4-羟苯基酮作为17β-羟类固醇脱氢酶(17β-HSD3)3型的强效和特异性抑制剂的抑制活性。

获取原文
获取原文并翻译 | 示例

摘要

We report the synthesis and biochemical evaluation of a number of 4-hydroxyphenyl ketones as potential inhibitors of the enzyme 17beta-hydroxysteroid dehydrogenase (17beta-HSD). In particular, we evaluated compounds against the catalysis of the conversion of androstenedione (AD) to testosterone (T) [17beta-HSD type 3 (17beta-HSD3)], furthermore, in an effort to determine the specificity of our compounds, we evaluated the ability of the compounds to inhibit the catalysis of the conversion of estrone (E1) to estradiol (E2) [17beta-HSD type 1 (17beta-HSD1)] as well as the conversion of dehydroepiandrosterone (DHEA) to AD [by 3beta-hydroxysteroid dehydrogenase (3beta-HSD)]. The results of our study suggest that the synthesised compounds are, in general, able to inhibit 17beta-HSD3 whilst being weak inhibitors of 17beta-HSD1. Against 3beta-HSD, we discovered that all of the synthesised compounds were weak inhibitors (all were found to possess less than 50% inhibition at [I]=500 microM). More specifically, we discovered that 1-(4-hydroxy-phenyl)-nonan-1-one (15) was the most potent against 17beta-HSD3 (IC(50)=2.9 microM) whilst possessing poor inhibitory activity against 17beta-HSD1 ( approximately 36% inhibitory activity against this reaction at [I]=100 microM) and less than 10% inhibition for the conversion of DHEA to AD. We have therefore provided good lead compounds in the design and synthesis of novel non-steroidal inhibitors of 17beta-HSD3.
机译:我们报告的合成和生化评估的许多4-羟苯基酮作为酶17β-羟类固醇脱氢酶(17beta-HSD)的潜在抑制剂。特别是,我们评估了化合物对抗雄烯二酮(AD)转化为睾丸激素(T)[17β-HSD3型(17β-HSD3)]的催化作用,此外,为了确定我们化合物的特异性,我们评估了化合物抑制雌酮(E1)转化为雌二醇(E2)[17beta-HSD 1型(17beta-HSD1)]的能力以及脱氢表雄酮(DHEA)转化为AD的能力[3beta-羟类固醇脱氢酶(3beta-HSD)]。我们的研究结果表明,合成的化合物通常能够抑制17beta-HSD3,同时又是17beta-HSD1的弱抑制剂。针对3beta-HSD,我们发现所有合成的化合物均为弱抑制剂(在[I] = 500 microM时,所有化合物的抑制作用均低于50%)。更具体地说,我们发现1-(4-羟基-苯基)-壬南-1-酮(15)对17beta-HSD3最有效(IC(50)= 2.9 microM),而对17beta-HSD1的抑制作用较弱(在[I] = 100 microM时,对该反应的抑制活性约为36%),对于DHEA转化为AD的抑制作用小于10%。因此,我们在设计和合成新型17beta-HSD3非甾类抑制剂中提供了良好的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号